Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA)

Historical Holders from Q3 2020 to Q3 2025

Symbol
ATHA on Nasdaq
Type / Class
Equity / Common Stock, $0.0001 Par Value
Shares outstanding
9.65M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
1.05K
Holdings value
$595
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
2
Number of sells
-48
Average Value change %
0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ACORN BIOVENTURES, L.P. 5.2% $1.13M 502K Anders Hove 22 Dec 2025
Oliveira Steven Michael 4.09% -20.4% $69.3K -$788K 161K -91.9% Oliveira Steven Michael 01 Oct 2025

Institutional Holders of Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 1.05K $595 -$5.29M $2.26 2
2025 Q2 17.5M $5.3M +$4.11K $0.30 50
2025 Q1 17.6M $5M -$112K $0.28 52
2024 Q4 17.9M $10.5M +$1.17M $0.59 54
2024 Q3 16.1M $7.19M -$16.9M $0.45 56
2024 Q2 22.2M $58.8M +$1.28M $2.65 65
2024 Q1 21.7M $59.4M -$117K $2.74 73
2023 Q4 21.9M $53.2M -$1.83M $2.43 64
2023 Q3 21.4M $43.3M -$1.35M $2.02 70
2023 Q2 21.9M $64.6M -$5.41M $2.95 76
2023 Q1 23.8M $59.5M +$2.34M $2.50 81
2022 Q4 21.8M $69.1M +$2.75M $3.17 92
2022 Q3 22.1M $65.6M +$171K $2.97 94
2022 Q2 22M $67M -$100M $3.05 89
2022 Q1 26.1M $352M +$184K $13.50 99
2021 Q4 26.2M $341M +$17.6M $13.03 97
2021 Q3 24.9M $234M +$136K $9.38 91
2021 Q2 24.7M $253M -$61.4M $10.24 86
2021 Q1 26.3M $484M +$83.8M $18.40 68
2020 Q4 21.5M $733M +$29.3M $34.25 69
2020 Q3 21.7M $395M +$395M $18.46 54